Moderna, Inc. (MRNA)
NASDAQ: MRNA · Real-Time Price · USD
27.12
+0.90 (3.43%)
At close: Aug 22, 2025, 4:00 PM
27.12
0.00 (0.00%)
After-hours: Aug 22, 2025, 4:19 PM EDT
Moderna Stock Forecast
Stock Price Forecast
The 17 analysts that cover Moderna stock have a consensus rating of "Hold" and an average price target of $42.41, which forecasts a 56.38% increase in the stock price over the next year. The lowest target is $15 and the highest is $70.
Price Target: $42.41 (+56.38%)
Analyst Consensus: Hold
Analyst Ratings
The average analyst rating for Moderna stock is "Hold". This means that analysts believe this stock is likely to perform similarly to the overall market.
Recommendation Trends
| Rating | Mar '25 | Apr '25 | May '25 | Jun '25 | Jul '25 | Aug '25 |
|---|---|---|---|---|---|---|
| Strong Buy | 2 | 2 | 2 | 2 | 2 | 2 |
| Buy | 1 | 1 | 1 | 1 | 1 | 1 |
| Hold | 14 | 14 | 13 | 13 | 13 | 12 |
| Sell | 3 | 3 | 3 | 3 | 4 | 5 |
| Strong Sell | 0 | 0 | 0 | 0 | 0 | 0 |
| Total | 20 | 20 | 19 | 19 | 20 | 20 |
Latest Forecasts
| Analyst | Firm | Rating | Rating | Action | Price Target | Upside | Date |
|---|---|---|---|---|---|---|---|
| Leerink Partners | Leerink Partners | Sell Maintains $18 → $15 | Sell | Maintains | $18 → $15 | -44.69% | Aug 22, 2025 |
| Barclays | Barclays | Hold Maintains $40 → $31 | Hold | Maintains | $40 → $31 | +14.31% | Aug 4, 2025 |
| B of A Securities | B of A Securities | Sell Maintains $26 → $25 | Sell | Maintains | $26 → $25 | -7.82% | Jul 22, 2025 |
| JP Morgan | JP Morgan | Sell Maintains $33 → $26 | Sell | Maintains | $33 → $26 | -4.13% | May 22, 2025 |
| UBS | UBS | Strong Buy Maintains $78 → $70 | Strong Buy | Maintains | $78 → $70 | +158.11% | May 2, 2025 |
Financial Forecast
Revenue This Year
1.97B
from 3.24B
Decreased by -39.22%
Revenue Next Year
2.17B
from 1.97B
Increased by 10.17%
EPS This Year
-9.98
from -9.28
EPS Next Year
-8.07
from -9.98
Historical EPS numbers are GAAP, while forecasted numbers may be non-GAAP.
Revenue Forecast
| Revenue | 2025 | 2026 | 2027 | 2028 | 2029 |
|---|---|---|---|---|---|
| High | 2.4B | 3.2B | 4.1B | ||
| Avg | 2.0B | 2.2B | 2.7B | ||
| Low | 1.5B | 1.3B | 1.6B |
Revenue Growth
| Revenue Growth | 2025 | 2026 | 2027 | 2028 | 2029 |
|---|---|---|---|---|---|
| High | -26.1% | 61.0% | 87.4% | ||
| Avg | -39.2% | 10.2% | 24.4% | ||
| Low | -53.3% | -33.2% | -27.8% |
EPS Forecast
| EPS | 2025 | 2026 | 2027 | 2028 | 2029 |
|---|---|---|---|---|---|
| High | -9.18 | -6.00 | -2.72 | ||
| Avg | -9.98 | -8.07 | -5.41 | ||
| Low | -10.50 | -9.93 | -6.63 |
EPS Growth
| EPS Growth | 2025 | 2026 | 2027 | 2028 | 2029 |
|---|---|---|---|---|---|
| High | - | - | - | ||
| Avg | - | - | - | ||
| Low | - | - | - |
Sources: Price targets and analyst ratings provided by Benzinga. Revenue and EPS forecast data provided by Finnhub. The data is sourced from Wall Street analysts. Data disclaimer.